Search

Search Constraints

You searched for: Author/Creator Jones, Jeffrey A.

Search Results

1. A phase I trial of the intravenous Hsp90 inhibitor alvespimycin (17-DMAG) in patients with relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma. Issue 9 (1st September 2016)

2. A phase II study of two dose levels of ofatumumab induction followed by maintenance therapy in symptomatic, previously untreated chronic lymphocytic leukemia. Issue 10 (22nd July 2016)

3. A single‐institution retrospective cohort study of first‐line R‐EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor. (28th November 2017)

4. Complete response to induction therapy in patients with Myc‐positive and double‐hit non‐Hodgkin lymphoma is associated with prolonged progression‐free survival. Issue 11 (27th February 2014)

5. Complete response to induction therapy in patients with Myc‐positive and double‐hit non‐Hodgkin lymphoma is associated with prolonged progression‐free survival. Issue 11 (27th February 2014)

6. Elevated Wall Tension Leads to Reduced miR‐133a in the Thoracic Aorta by Exosome Release. Issue 1 (8th January 2019)

7. Externally validated predictive clinical model for untreated del(17p13.1) chronic lymphocytic leukemia patients. Issue 11 (12th October 2015)

8. Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non‐Hodgkin's lymphoma. Issue 1 (30th September 2013)

9. HDACs Regulate miR-133a Expression in Pressure Overload–Induced Cardiac Fibrosis. (November 2015)